Cryptococcal meningitis following umbilical cord blood transplantation, association between the occurrence of cryptococcal infection and tacrolimus discontinuation among allogeneic hematopoietic stem cell recipients

J Infect Chemother. 2019 Apr;25(4):289-292. doi: 10.1016/j.jiac.2018.09.006. Epub 2018 Oct 10.

Abstract

Few cases of cryptococcal infection following umbilical cord blood transplantation (UCBT) have been reported. We report a case, where cryptococcal infection occurred soon after rapidly reducing the dose of tacrolimus in a UCBT recipient who received micafungin prophylaxis during the early phase of transplantation. The etiology of cryptococcal infection following allogeneic hematopoietic stem cell transplantation (allo-HSCT), including UCBT, might be associated with rapid dose-reduction of calcineurin inhibitors, such as tacrolimus during early phase of allo-HSCT. To our knowledge, this is the first English-language report to describe in detail a case of cryptococcal meningitis with fungemia during early phase of UCBT.

Keywords: Allogeneic hematopoietic stem cell transplantation; Calcineurin inhibitor; Cryptococcosis; Micafungin breakthrough; Tacrolimus; Umbilical cord blood transplantation.

Publication types

  • Case Reports

MeSH terms

  • Antibiotic Prophylaxis / methods
  • Antifungal Agents / pharmacology
  • Antifungal Agents / therapeutic use
  • Calcineurin Inhibitors / administration & dosage*
  • Cord Blood Stem Cell Transplantation / adverse effects*
  • Cryptococcus neoformans / drug effects
  • Cryptococcus neoformans / isolation & purification
  • Dose-Response Relationship, Drug
  • Fungemia / microbiology*
  • Fungemia / prevention & control
  • Graft vs Host Disease / prevention & control
  • Hematopoietic Stem Cell Transplantation / adverse effects*
  • Humans
  • Male
  • Meningitis, Cryptococcal / microbiology*
  • Meningitis, Cryptococcal / prevention & control
  • Micafungin / pharmacology
  • Micafungin / therapeutic use
  • Middle Aged
  • Tacrolimus / administration & dosage*
  • Transplantation, Homologous / adverse effects

Substances

  • Antifungal Agents
  • Calcineurin Inhibitors
  • Micafungin
  • Tacrolimus